Oct 20,2021

ABBOTT REPORTS THIRD-QUARTER 2021 RESULTS; ACHIEVES STRONG DOUBLE-DIGIT EARNINGS GROWTH AND RAISES GUIDANCE

"We achieved another quarter of strong growth overall and across all four of our major business areas," said Robert B. Ford, president and chief executive officer, Abbott. "We're particularly pleased with the continued advancements of our new product pipeline, including several recent launches in large, high-growth markets."

View Analyst & Ambassador Comments
Go to original news
Oct 21,2021

Liva Healthcare appoints Dr Naresh Kanumilli to power innovation in diabetes digital health coaching

Dr Kanumilli has been appointed as UK Medical Director for the digital health coaching company.

View Analyst & Ambassador Comments
Go to original news
Oct 22,2021

BD Names Dr. Carrie Byington To Board Of Directors

Byington, 58, is executive vice president and head of University of California Health (UCH), where she leads the nation's largest academic health system. UCH's six academic health centers and 20 health professional schools form a more than $20 billion enterprise providing nationally ranked care, health professional training and biomedical research. UCH's academic health centers specialize in complex care, including providing half of all transplants and one-fourth of extensive burn care in California. UCH operates or staffs five Level 1 trauma centers, five nationally designated comprehensive cancer centers and five clinical and translational science institutes.

View Analyst & Ambassador Comments
Go to original news
Oct 25,2021

Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues

Evidence indicates that poor glycemic control is associated with increased morbidity and length of stay in hospital. There are a wide range of guidelines published, which seek to ensure safe and effective inpatient glycemic control in the hospital setting. However, the implementation of these protocols is limited in practice. In particular, the feasibility of “flash” and continuous glucose monitoring (CGM) remains untested on general wards.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 25,2021

DarioHealth Announces Contract with a U.S. National Employer to Provide Its Full Multi-Condition Suite Digital Therapeutic Solutions

DarioHealth Corp. ("Dario," "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into a contract with a U.S. national employer (the "Employer") for the Company's full multi-condition suite of chronic condition management solutions, including diabetes, pre-diabetes, hypertension, musculoskeletal, behavioral health, and digital employee assistance programs. Enrollment of the Company's multi-condition suite of chronic condition management solutions is expected to begin in the first quarter of 2022, consistent with the Employer's benefit year.

#dtx

View Analyst & Ambassador Comments
Go to original news
Oct 26,2021

BD to Host Investor Day on November 12

BD, a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will last for approximately four hours. The event will feature presentations from Tom Polen, chairman, chief executive officer and president of the company, and other key members of the executive leadership team. Question and answer sessions will follow the presentations.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Oct 26,2021

LifeScan Launches OneTouch Solutions, A Holistic Digital Health Offering Linking People with Diabetes to Solutions and Support From Proven Experts

LifeScan, a world leader in blood glucose monitoring, serving more than 20 million people with diabetes and the maker of the iconic OneTouch brand products, announced the launch of OneTouch Solutions, an eCommerce site offering a comprehensive and convenient choice of personalized wellness programs to help people not just manage diabetes, but thrive. OneTouch Solutions is available now to consumers in the US, and will soon be offered to healthcare providers, payors, and employers as a reimbursed adjudicated option in early 2022.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Oct 26,2021

Glytec Awarded First Patient Safety Solutions Agreement with Premier

Glytec – the only provider of cloud-based insulin management software across the continuum of care, today announced that it has been awarded a group purchasing agreement with Premier and will be the organization’s sole supplier of glycemic management software in the newly-created patient safety solutions category. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Glytec’s eGlycemic Management System® (eGMS).

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Oct 26,2021

Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2021 financial results after market close on Tuesday, November 9, 2021.

View Analyst & Ambassador Comments
Go to original news
Oct 27,2021

One Drop Delivers Novel AI-Powered Solution for Cardiovascular Disease Prevention

One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced the release of a digital, AI-enabled cardiovascular disease (CVD) prevention module. The new CVD prevention module is the first co-developed digital product to emerge from the collaboration between One Drop and Bayer in support of One Drop’s expansion into a wide range of therapeutic areas.

PRODUCT

#mobile app

#dtx

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES